BRIEF-Galapagos regains full rights to bowel drug By: Reuters: Company News December 16, 2014 at 01:41 AM EST * Galapagos regains full rights to GPR84 inhibitor GLPG1205 Read More >> Related Stocks: Johnson & Johnson